SENSEX NIFTY

Sanofi Aventis

Sep 23, 2013 at 09:56 | Source: Moneycontrol.com
Genzyme, a fully-owned subsidiary of drug major Sanofi-Aventis, alleged that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts.
Sep 22, 2013 at 13:58 | Source: PTI
In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with US FDA seeking approval to engage in the commercial manufacture, importation, use, and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil drug.
Sep 16, 2013 at 15:54 | Source: Moneycontrol.com
Pharma major, Lupin, announced today that it has received final approval for its Zolpidem Tartrate Extended-release tablets USP, 6.25 mg and 12.5 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Sanofi Aventis, US, LLCs (Sanofi) Ambien CR Extended-release tablets, 6.25 mg and 12.5 mg.
Jun 26, 2013 at 18:46 | Source: Moneycontrol.com
The stock hit 5 percent upper circuit limit on Wednesday following a report that companies like Sanofi Aventis, Novartis and GlaxoSmithKline were in the race to buy out the company's domestic formulations business.
Jun 26, 2013 at 12:12 | Source: Moneycontrol.com
The report states that Sanofi and GSK have put in non-binding bids and Novartis has signed a non-disclosure agreement to acquire the domestic formulations business of Elder Pharma.
Jun 16, 2013 at 21:30 | Source: PTI
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
Feb 19, 2013 at 22:31 | Source: PTI
Sanofi India (previously known as Aventis Pharma) on Tuesday said it aims to double its consumer healthcare business in the next five years
Feb 15, 2013 at 15:43 | Source: Moneycontrol.com
The Andhra Pradesh High Court (HC) today said that French drug giant Sanofi Aventis need not pay capital gain tax as demanded by Income Tax (I-T) department for acquisition of Shantha Biotech in 2009.
Oct 17, 2012 at 15:00 | Source: PTI
Pharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drugs Administration to market a generic version of Sanofi Aventis's Avapro tablets.
Oct 17, 2012 at 14:51 | Source: PTI
Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA) to market a generic version of Sanofi Aventis's Avapro tablets.
Messages on Sanofi Aventis »

Poppee55

Platinum Member

337 Followers

Sun Pharma  

Sun Pharma has got tentative USFDA approvals for fexofenadine pseudoephedrine hydrochlorides combination which is currently sold under brand name of Allegra D (annual sales approximately US$400mn). Sun Pharma has settlement with innovator Sanofi Aventis to launch the product before patent expiry

10.05 AM Apr 4th

Web Messenger

Platinum Member

228725 Followers

News Now  

Source:VC Circle - Sanofi Aventis is investing Rs 755 crore to buy out the remaining minority shareholders of Shantha Biotechnics Ltd and fund its further expansion plans, spokesperson of the French drugmaker told VCCircle. This follows the nod from the Foreign

12.05 PM Nov 2nd 2013

Web Messenger

Platinum Member

228725 Followers

Lupin  

Source:VC Circle - Mumbai-based pharma major Lupin Ltd has received the final approval from US Food and Drug Administration (FDA) to manufacture and market in the US a generic version of Sanofi Aventis' Ambien CR Extended-release tablets, used in treating sleep 

6.18 PM Sep 18th 2013

Firstpost

Platinum Member

867 Followers

Lupin  

Source:FirstPost - New Delhi: Drug major Lupin today said it has received US health regulator`s approval to market a generic version of Sanofi Aventis` Ambien CR Extended-release tablets, used in treating sleep disorders, in the American market.The company has received final approval from the US

6.15 PM Sep 16th 2013

Web Messenger

Platinum Member

228725 Followers

Lupin  

Source:The Hindu BusinessLine - Lupin has received the US health regulator’s approval to market a generic version of Sanofi Aventis’ Rifadin capsules, used to treat tuberculosis, in the American market. The company’s US-based subsidiary Lupin Pharmaceuticals Inc has received final approval from

11.07 AM Aug 24th 2013

MMB Moderator

Platinum Member

2307 Followers

Sun Pharma  

to the drug regulator`s website. The company had earlier received tentative approval for the drug from the US FDA in 2010. Riluzole is a generic version of Sanofi Aventis` Rilutek. Sanofi sold US rights for Rilutek and a few other drugs to Covis Pharma earlier this year. Sun Pharma`s Indian rival Glenmark

12.26 PM Jun 22nd 2013

k.v.renga

Platinum Member

335 Followers

Sun Pharma  

for the drug from the US FDA in 2010. Riluzole is a generic version of Sanofi Aventis` Rilutek. Sanofi sold US rights for Rilutek and a few other drugs to Covis Pharma earlier this year. Sun Pharma`s Indian rival Glenmark had also announced earlier this week that its US generics arm received FDA approval

8.33 PM Jun 21st 2013

Mikki Mouse

Platinum Member

56 Followers

Sterling Bio  

or even years to get it revoked and Indian companies like Lupin and Aurobindo have got clearance from the USFDA after getting a warning or an import alert (see Under the FDA Scanner). Even global pharma majors are not exempt from this. For instance, Novartis Intl AG and Sanofi Aventis Deutschland GmbH got

1.06 PM May 27th 2013

Web Messenger

Platinum Member

228725 Followers

Other Market Topics  

Source:DNA India - In a landmark judgment, the Andhra Pradesh High Court (APHC) on Friday ruled that the French drugmaker Sanofi Aventis, which (by buying another French firm ShanH) had acquired a 90% stake in the Hyderabad-based vaccine-maker Shantha Biotech in 2009, need not pay tax in India

4.04 PM Feb 16th 2013

Web Messenger

Platinum Member

228725 Followers

Lupin  

Source:Business Standard - Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA). The tablets are available in 75-300 mg strengths and are the AB-rated generic equivalent of Sanofi Aventis`s Avapro

1.16 PM Oct 18th 2012

News across the web »
Feb 02, 2014 at 12:27 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.